Manuela Colafigli

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Mattia Prosperi, Massimiliano Fabbiani, Iuri Fanti et al. · BMC Infectious Diseases · 2012 · 90 citations · Full text

Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in <scp>HIV</scp>‐infected patients

Massimiliano Fabbiani, Nicoletta Ciccarelli, M Tana et al. · HIV Medicine · 2012 · 84 citations · Full text

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán et al. · Journal of Antimicrobial Chemotherapy · 2016 · 75 citations · Full text

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study

Andrea De Luca, Katleen de Gaetano Donati, Manuela Colafigli et al. · BMC Infectious Diseases · 2013 · 61 citations · Full text

Revised Central Nervous System Neuropenetration-Effectiveness Score is Associated with Cognitive Disorders in HIV-Infected Patients with Controlled Plasma Viraemia

Nicoletta Ciccarelli, Massimiliano Fabbiani, Manuela Colafigli et al. · Antiviral Therapy · 2013 · 58 citations